Cargando…

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer

Genetic alterations identified in adjacent normal appearing tissue in bladder cancer patients are indicative of a field disease. Here we assessed normal urothelium transformation and intra-tumour heterogeneity (ITH) in four patients with bladder cancer. Exome sequencing identified private acquired m...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomsen, Mathilde Borg Houlberg, Nordentoft, Iver, Lamy, Philippe, Vang, Søren, Reinert, Line, Mapendano, Christophe Kamungu, Høyer, Søren, Ørntoft, Torben F., Jensen, Jørgen Bjerggaard, Dyrskjøt, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600970/
https://www.ncbi.nlm.nih.gov/pubmed/28916750
http://dx.doi.org/10.1038/s41598-017-11291-0
_version_ 1783264304550641664
author Thomsen, Mathilde Borg Houlberg
Nordentoft, Iver
Lamy, Philippe
Vang, Søren
Reinert, Line
Mapendano, Christophe Kamungu
Høyer, Søren
Ørntoft, Torben F.
Jensen, Jørgen Bjerggaard
Dyrskjøt, Lars
author_facet Thomsen, Mathilde Borg Houlberg
Nordentoft, Iver
Lamy, Philippe
Vang, Søren
Reinert, Line
Mapendano, Christophe Kamungu
Høyer, Søren
Ørntoft, Torben F.
Jensen, Jørgen Bjerggaard
Dyrskjøt, Lars
author_sort Thomsen, Mathilde Borg Houlberg
collection PubMed
description Genetic alterations identified in adjacent normal appearing tissue in bladder cancer patients are indicative of a field disease. Here we assessed normal urothelium transformation and intra-tumour heterogeneity (ITH) in four patients with bladder cancer. Exome sequencing identified private acquired mutations in a lymph node metastasis and local recurrences. Deep re-sequencing revealed presence of at least three and four subclones in two patients with multifocal disease, while no demarcation of subclones was identified in the two patients with unifocal disease. Analysis of adjacent normal urothelium showed low frequency mutations in patients with multifocal disease. Expression profiling showed intra-tumour and intra-patient co-existence of basal- and luminal-like tumour regions, and patients with multifocal disease had a greater degree of genomic and transcriptomic ITH, as well as transformation of adjacent normal cells, compared to patients with unifocal disease. Analysis of the adjacent urothelium may pave the way for therapies targeting the field disease.
format Online
Article
Text
id pubmed-5600970
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56009702017-09-20 Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer Thomsen, Mathilde Borg Houlberg Nordentoft, Iver Lamy, Philippe Vang, Søren Reinert, Line Mapendano, Christophe Kamungu Høyer, Søren Ørntoft, Torben F. Jensen, Jørgen Bjerggaard Dyrskjøt, Lars Sci Rep Article Genetic alterations identified in adjacent normal appearing tissue in bladder cancer patients are indicative of a field disease. Here we assessed normal urothelium transformation and intra-tumour heterogeneity (ITH) in four patients with bladder cancer. Exome sequencing identified private acquired mutations in a lymph node metastasis and local recurrences. Deep re-sequencing revealed presence of at least three and four subclones in two patients with multifocal disease, while no demarcation of subclones was identified in the two patients with unifocal disease. Analysis of adjacent normal urothelium showed low frequency mutations in patients with multifocal disease. Expression profiling showed intra-tumour and intra-patient co-existence of basal- and luminal-like tumour regions, and patients with multifocal disease had a greater degree of genomic and transcriptomic ITH, as well as transformation of adjacent normal cells, compared to patients with unifocal disease. Analysis of the adjacent urothelium may pave the way for therapies targeting the field disease. Nature Publishing Group UK 2017-09-15 /pmc/articles/PMC5600970/ /pubmed/28916750 http://dx.doi.org/10.1038/s41598-017-11291-0 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Thomsen, Mathilde Borg Houlberg
Nordentoft, Iver
Lamy, Philippe
Vang, Søren
Reinert, Line
Mapendano, Christophe Kamungu
Høyer, Søren
Ørntoft, Torben F.
Jensen, Jørgen Bjerggaard
Dyrskjøt, Lars
Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
title Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
title_full Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
title_fullStr Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
title_full_unstemmed Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
title_short Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
title_sort comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600970/
https://www.ncbi.nlm.nih.gov/pubmed/28916750
http://dx.doi.org/10.1038/s41598-017-11291-0
work_keys_str_mv AT thomsenmathildeborghoulberg comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT nordentoftiver comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT lamyphilippe comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT vangsøren comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT reinertline comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT mapendanochristophekamungu comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT høyersøren comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT ørntofttorbenf comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT jensenjørgenbjerggaard comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer
AT dyrskjøtlars comprehensivemultiregionalanalysisofmolecularheterogeneityinbladdercancer